Chautauqua Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Chautauqua Capital Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$3.32M	Sell	6,121 -294	-5%	-$159K	1.05%	16
2015 Q3	$2.98M	Sell	6,415 -16,298	-72%	-$8.75M	0.98%	17
2015 Q2	$11.6M	Buy	22,713 +234	+1%	+$114K	2.81%	11
2015 Q1	$10.1M	Buy	22,479 +11	+0%	+$4.66K	2.58%	12
2014 Q4	$9.22M	Buy	22,468 +487	+2%	+$192K	2.78%	12
2014 Q3	$7.92M	Hold	21,981	–	–	2.59%	9
2014 Q2	$6.21M	Sell	21,981 -20,231	-48%	-$6M	2.13%	10
2014 Q1	$12.7M	Hold	42,212	–	–	2.49%	11
2013 Q4	$11.6M	Buy	42,212 +18,004	+74%	+$5.18M	2.57%	11
2013 Q3	$7.57M	Buy	24,208 +12,104	+100%	+$3.18M	1.78%	15
2013 Q2	$2.72M	Buy	+12,104	New	+$2.82M	2.11%	20

Other funds holding REGN

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LTI

Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Chautauqua Capital Management's REGN Position: Q4 2015 in Review

Chautauqua Capital Management reduced its Regeneron Pharmaceuticals (REGN) stake by 4.6% in Q4 2015, selling an estimated $159K and leaving 6,121 shares worth $3.32M. The position accounts for 1.05% of the portfolio, ranked #16.

Chautauqua Capital Management first reported a position in REGN in Q2 2013 and has held it in 11 quarters since. The position peaked at $12.7M in Q1 2014. 575 funds tracked by Wall St. Rank hold REGN as of Q4 2015.

Chautauqua Capital Management held 6,121 shares of Regeneron Pharmaceuticals worth $3.32M as of Q4 2015.
Chautauqua Capital Management sold 294 Regeneron Pharmaceuticals shares in Q4 2015, an estimated $159K.
Regeneron Pharmaceuticals made up 1.05% of Chautauqua Capital Management's portfolio in Q4 2015, its #16 holding.
Chautauqua Capital Management first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 11 quarters since.
Chautauqua Capital Management's Regeneron Pharmaceuticals position peaked at $12.7M in Q1 2014.
575 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2015.

Based on Chautauqua Capital Management's 13F filing for Q4 2015, filed 22 Jan 2016.